NIAID solicits proposals for CBRN countermeasures
NIAID is specifically looking for proposals that could be labeled under "Development of Medical Countermeasures to Enhance Platelet Regeneration and Survival Following Radiation Exposure from a Radiological/Nuclear Incident." The goal of the proposals and following contracts would be to advance the development of medical countermeasures and enhance platelet regeneration after exposure to radiation.
The NIAID thinks that the research and development from the studies that come out of these proposals will eventually be supported by the Broad Agency Announcement. They would then move on to be approved by the Food and Drug Administration.
Proposals are evaluated on the data supporting the amelioration of radiation-induced thrombocytopenia, improved survival and the comprehensiveness, soundness, adequacy and suitability of the proposed approach and methodology used to support the advancement of the proposals.
Proposals that are offered a contract are expected to be offered a two to four cost reimbursement. Completion type contracts will be awarded for a three year period and will begin at or around the summer of 2014.